rs6867
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001753.5(CAV1):c.*1182G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.19 in 152,102 control chromosomes in the GnomAD database, including 3,180 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.19 ( 3180 hom., cov: 32)
Exomes 𝑓: 0.045 ( 0 hom. )
Consequence
CAV1
NM_001753.5 3_prime_UTR
NM_001753.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.418
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
?
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.289 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CAV1 | NM_001753.5 | c.*1182G>A | 3_prime_UTR_variant | 3/3 | ENST00000341049.7 | ||
CAV1 | NM_001172895.1 | c.*1182G>A | 3_prime_UTR_variant | 3/3 | |||
CAV1 | NM_001172896.2 | c.*1182G>A | 3_prime_UTR_variant | 2/2 | |||
CAV1 | NM_001172897.2 | c.*1182G>A | 3_prime_UTR_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CAV1 | ENST00000341049.7 | c.*1182G>A | 3_prime_UTR_variant | 3/3 | 1 | NM_001753.5 | P3 | ||
CAV1 | ENST00000393467.1 | c.*1182G>A | 3_prime_UTR_variant | 2/2 | 1 | A1 | |||
CAV1 | ENST00000405348.6 | c.*1182G>A | 3_prime_UTR_variant | 3/3 | 5 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.190 AC: 28891AN: 151962Hom.: 3178 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
28891
AN:
151962
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0455 AC: 1AN: 22Hom.: 0 Cov.: 0 AF XY: 0.0556 AC XY: 1AN XY: 18
GnomAD4 exome
AF:
AC:
1
AN:
22
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
18
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.190 AC: 28930AN: 152080Hom.: 3180 Cov.: 32 AF XY: 0.183 AC XY: 13630AN XY: 74366
GnomAD4 genome
?
AF:
AC:
28930
AN:
152080
Hom.:
Cov.:
32
AF XY:
AC XY:
13630
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
309
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at